PSP Research LLC has disclosed its latest investment holdings through a 13F filing, revealing a total portfolio value of approximately $145.8 million as of September 30, 2026. This filing is significant as it showcases the firm’s strategic focus on biotechnology and pharmaceutical investments, sectors that have garnered increasing attention in recent years.
The filing, submitted on October 21, 2026, highlights the firm’s commitment to the healthcare sector, which has been a focal point for many investors navigating the complexities of the post-pandemic economy. The report indicates that PSP Research LLC holds shares in several prominent companies within the biotechnology and pharmaceutical industries, including Alkermes PLC and Arcutis Biotherapeutics Inc.
Background
PSP Research LLC is an investment firm based in Las Vegas, Nevada, incorporated in Pennsylvania. The firm specializes in managing investment portfolios and is categorized under the SEC’s other entity type. Recent filings from PSP Research LLC include a series of 13F-HR forms, with the latest being filed on October 21, 2026, and detailing the firm’s holdings as of the end of September 2026.
What the Filing Says
The 13F filing submitted by PSP Research LLC indicates that the firm has a total of 44 entries in its portfolio, with a reported total value of $145,831,410. The filing emphasizes that the firm has sole investment discretion over these holdings, reflecting its strategic approach to investment management.
Impact
This update from PSP Research LLC may influence various stakeholders, including current and potential investors, as well as companies within the biotechnology and pharmaceutical sectors. By showcasing its investment strategy and portfolio, PSP Research LLC provides insights into market trends and investor sentiment in these critical industries.
What's Next
The filing does not specify what happens next for PSP Research LLC, but it is expected that the firm will continue to monitor its investments closely and may make further disclosures in future filings.